A prospective cohort study to evaluate osteopontin levels as a biomarker in bio-naive patients with rheumatoid arthritis treated with toclizumab or infiximab.
Phase of Trial: Phase IV
Latest Information Update: 14 Jul 2015
At a glance
- Drugs Infliximab (Primary) ; Tocilizumab (Primary) ; Methotrexate; Prednisolone
- Indications Rheumatoid arthritis
- Focus Biomarker; Therapeutic Use
- 14 Jul 2015 New trial record